⌘K

Login Start Free

Home/Filings/4/0001628280-24-000279

4//SEC Filing

Ondrey Aaron 4

Accession 0001628280-24-000279

CIK 0001576263other

View on SEC.gov Company Profile

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 5:55 PM ET

Size

4.6 KB

Accession

0001628280-24-000279

Insider Transaction Report

Form 4

Period: 2023-12-29

Mirati Therapeutics, Inc.MRTX

Interim CFO

Transactions

Award
Common Stock
2023-12-29$58.75/sh+17,021$999,984→ 39,461 total

Footnotes (1)

[F1]Grant of Restricted Stock Units (RSUs). Shares will vest 25% annually on the anniversary of the grant date until fully vested.

Documents

1 file

4
wk-form4_1704322481.xmlPrimary
FORM 4

Issuer

Mirati Therapeutics, Inc.

CIK 0001576263

Entity typeother

Related Parties

1

filerCIK 0001991078

Filing Metadata

Form type: 4
Filed: Jan 2, 7:00 PM ET
Accepted: Jan 3, 5:55 PM ET
Size: 4.6 KB

View on SEC.gov